At the news
? NEUTRALIMPACT 1/10 6-K filed Sep 11, 2026 at 10:30 ET
This 6-K filing reports routine acquisitions of GSK ordinary shares by multiple PDMRs (senior executives) under the company's Share Reward Plan on September 9, 2026. Each PDMR acquired 14 shares (7 partnership + 7 matching) at £18.0296 per share. The transactions are plan-based and de minimis in size, representing no material signal for the stock.
- Nine PDMRs (including CFO Julie Brown, President Europe, President Corporate Development, CEO ViiV Healthcare) each acquired 14 ordinary shares under the Share Reward Plan
- All acquisitions executed on September 9, 2026 at £18.0296 per share on the London Stock Exchange
- Each PDMR received 7 partnership shares and 7 matching shares, standard plan structure
- Total shares acquired across all PDMRs: 126 shares (approximately £2,272 aggregate value)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access